Utility of circulating tumor DNA for detection and monitoring of endometrial cancer recurrence and progression
Esther L. Moss, Diviya N. Gorsia, Anna Collins, Pavandeep Sandhu, Nalini Foreman, Anu Gore, Joey Wood, Christopher Kent, Elizabeth A. Stannard, Lee Silcock, View ORCID ProfileDavid S. Guttery
doi: https://doi.org/10.1101/2020.03.04.20030908
Esther L. Moss
1Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, Leicester, LE2 7LX, UK
2Department of Gynaecological Oncology, University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, LE5 4PW, UK
Diviya N. Gorsia
1Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, Leicester, LE2 7LX, UK
Anna Collins
1Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, Leicester, LE2 7LX, UK
Pavandeep Sandhu
1Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, Leicester, LE2 7LX, UK
Nalini Foreman
1Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, Leicester, LE2 7LX, UK
Anu Gore
2Department of Gynaecological Oncology, University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, LE5 4PW, UK
Joey Wood
2Department of Gynaecological Oncology, University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, LE5 4PW, UK
Christopher Kent
2Department of Gynaecological Oncology, University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, LE5 4PW, UK
Elizabeth A. Stannard
2Department of Gynaecological Oncology, University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, LE5 4PW, UK
Lee Silcock
3Nonacus Limited, Birmingham Research Park, Birmingham, B15 2SQ, UK
David S. Guttery
1Leicester Cancer Research Centre, College of Life Sciences, University of Leicester, Leicester, LE2 7LX, UK
Data Availability
All WES data will be deposited in the European Genome-Phenome Archive on publication.
Posted March 06, 2020.
Utility of circulating tumor DNA for detection and monitoring of endometrial cancer recurrence and progression
Esther L. Moss, Diviya N. Gorsia, Anna Collins, Pavandeep Sandhu, Nalini Foreman, Anu Gore, Joey Wood, Christopher Kent, Elizabeth A. Stannard, Lee Silcock, David S. Guttery
medRxiv 2020.03.04.20030908; doi: https://doi.org/10.1101/2020.03.04.20030908
Utility of circulating tumor DNA for detection and monitoring of endometrial cancer recurrence and progression
Esther L. Moss, Diviya N. Gorsia, Anna Collins, Pavandeep Sandhu, Nalini Foreman, Anu Gore, Joey Wood, Christopher Kent, Elizabeth A. Stannard, Lee Silcock, David S. Guttery
medRxiv 2020.03.04.20030908; doi: https://doi.org/10.1101/2020.03.04.20030908
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2774)
- Dermatology (237)
- Emergency Medicine (415)
- Epidemiology (12423)
- Forensic Medicine (10)
- Gastroenterology (786)
- Genetic and Genomic Medicine (4291)
- Geriatric Medicine (396)
- Health Economics (703)
- Health Informatics (2771)
- Health Policy (1026)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (405)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4066)
- Nursing (218)
- Nutrition (602)
- Oncology (2145)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (78)
- Pathology (480)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6672)
- Radiology and Imaging (1457)
- Respiratory Medicine (888)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (171)